Imatinib does not impair specific antitumor T-cell immunity in patients with chronic myeloid leukemia.

Authors :: Bocchia M
Abruzzese E
Forconi F
Ippoliti M
Trawinska MM
Pirrotta MT
Raspadori D
Tozzi M
Gozzetti A
Lauria F
Source :: Leukemia [Leukemia] 2006 Jan; Vol. 20 (1), pp. 142-3.
Publication Year :: 2006

Subjects :: Adolescent
Adult
Benzamides
CD4-Positive T-Lymphocytes drug effects
CD4-Positive T-Lymphocytes immunology
Child
Drug Screening Assays, Antitumor
Humans
Imatinib Mesylate
Immunization
Interferon-alpha therapeutic use
T-Lymphocytes drug effects
Immunity, Cellular drug effects
Leukemia, Myelogenous, Chronic, BCR-ABL Positive drug therapy
Piperazines therapeutic use
Pyrimidines therapeutic use
T-Lymphocytes immunology

Full Text Access

Tools